Linastar 5 mg contains Linagliptin, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor used in the management of type 2 diabetes. Linagliptin works by enhancing the effects of incretin hormones, which help regulate blood sugar levels by increasing insulin release and decreasing glucagon secretion in response to meals. Unlike other diabetes medications, Linagliptin does not cause weight gain and is not associated with a risk of hypoglycemia when used alone.
Linastar 5 mg helps to control blood sugar levels in adults with type 2 diabetes, making it an essential part of diabetes management, especially when lifestyle changes alone are insufficient.